Concomitant myasthenia gravis and macroprolactinoma: the immunomodulatory role of prolactin and its potential therapeutic use.

Harris, S M; Leong, H M C; Chowdhury, R; Ellis, C; Brennan, John; Scobie, I N

Harris, S M; Leong, H M C; Chowdhury, R; Ellis, C; Brennan, John; Scobie, I N.

Affiliation

Harris SM; Departments of Endocrinology, Neurology and Radiology, Medway Maritime Hospital, c/o Diabetes Centre, Residence 9, Gillingham, ME7 5NY, UK, sophieharris88@gmail.com.

Endocrine ; 45(1): 9-14, 2014 Feb.

Article in En | MEDLINE | ID: mdl-23749585

Subject(s)

Immunomodulation; Molecular Targeted Therapy; Myasthenia Gravis/complications; Pituitary Neoplasms/complications; Prolactin/physiology; Prolactinoma/complications; Humans; Male; Middle Aged; Molecular Targeted Therapy/trends; Myasthenia Gravis/diagnosis; Myasthenia Gravis/immunology; Myasthenia Gravis/therapy; Pituitary Neoplasms/diagnosis; Pituitary Neoplasms/immunology; Pituitary Neoplasms/therapy; Prolactin/antagonists & inhibitors; Prolactinoma/diagnosis; Prolactinoma/immunology; Prolactinoma/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Prolactin / Prolactinoma / Immunomodulation / Molecular Targeted Therapy / Myasthenia Gravis Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Endocrine Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google